JC virus leuko-encephalopathy in reduced intensity conditioning cord blood transplant recipient with a review of the literature

Mediterranean Journal of Hematology and Infectious Diseases

Volumn 4, Issue 1, 2012, Pages

  El Cheikh, Jean ^a   Fürst, Sabine ^a   Casalonga, Francois ^a   Crocchiolo, Roberto ^a   Castagna, Luca ^a   Granata, Angela ^a   Oudin, Claire ^a   Faucher, Catherine ^a   Berger, Pierre ^a   Sarran, Anthony ^a   Blaise, Didier ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; GANCICLOVIR; GLUCOSE; MEFLOQUINE; METHYLPREDNISOLONE; MIRTAZAPINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITROGEN; PROTEIN; STEROID; UREA; VIRUS DNA;

ADULT; ALLOTRANSPLANTATION; ARTICLE; AUTISM; BRAIN DAMAGE; BRAIN RADIOGRAPHY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID EXAMINATION; CONFUSION; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; DEMENTIA; DETERIORATION; DRUG DOSE REDUCTION; DYSPHAGIA; ELECTROENCEPHALOGRAM; FEMALE; FOLLICULAR LYMPHOMA; FUNCTIONAL DISEASE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMOLYTIC ANEMIA; HUMAN; IMMUNOCOMPROMISED PATIENT; JC VIRUS; LEUKOCYTE COUNT; LOW DRUG DOSE; MEMORY DISORDER; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; POLYMERASE CHAIN REACTION; POLYOMAVIRUS INFECTION; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REDUCED INTENSITY CONDITIONING; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; VIRUS DETECTION; VIRUS REACTIVATION; VISUAL DISORDER; WEAKNESS; WHOLE BODY RADIATION;

EID: 84875983697     PISSN: None     EISSN: 20353006     Source Type: Journal    
DOI: 10.4084/MJHID.2012.043     Document Type: Article

References (41)

1. Koralnik IJ. New insights into progressive multifocal leukoencephalopathy. Curr Opin. Neurol. 2004; 17: 365-370. http://dx.doi.org/10.1097/00019052-200406000-00019 PMid:15167073
2. Vaklavas C, Sotelo-Rafiq EP, Lovy J, Escobar MA, Tsimberidou AM. Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression. Virol. J 2010; 7: 256. http://dx.doi.org/10.1186/1743-422X-7-256 PMid:20920200 PMCid:2954859
3. Bellizzi A, Barucca V, Fioriti D, Colosimo MT, Mischitelli M, Anzivino E et al. Early years of biological agents therapy in Crohn's disease and risk of the human polyomavirus JC reactivation. J Cell Physiol 2010; 224: 316-326. http://dx.doi.org/10.1002/jcp.22146 PMid:20432445
4. Bellizzi A, Barucca V, Di NG, Fioriti F, Iebba V, Schippa S et al. JC Viral reactivation in a pediatric patient with Crohn's disease. Int J Immunopathol. Pharmacol. 2010; 23: 955-959. PMid:20943069
5. Achiron A, Miron S, Shoenfeld Y. Does the flap of a butterfly's wings in Brazil set off a tornado in Texas?-The JC Virus Story in multiple sclerosis. Isr. Med Assoc. J 2005; 7: 283-285. PMid:15909458
6. Agostini HT, Ryschkewitsch CF, Singer EJ, Stoner GL. Co-infection with two JC virus genotypes in brain, cerebrospinal fluid or urinary tract detected by direct cycle sequencing of PCR products. J Neurovirol. 1996; 2: 259-267. http://dx.doi.org/10.3109/13550289609146889 PMid:8799217
7. Alvarez-Lafuente R, Garcia-Montojo M, de LH, V, Bartolome M, Arroyo R. JC virus in cerebrospinal fluid samples of multiple sclerosis patients at the first demyelinating event. Mult. Scler. 2007; 13: 590-595. http://dx.doi.org/10.1177/1352458506073116 PMid:17548437
8. ASTROM KE, MANCALL EL, RICHARDSON EP, Jr. Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 1958; 81: 93-111. PMid:13523006
9. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971; 1: 1257-1260. http://dx.doi.org/10.1016/S0140-6736(71)91777-6
10. Berger JR, Chauhan A, Galey D, Nath A. Epidemiological evidence and molecular basis of interactions between HIV and JC virus. J Neurovirol. 2001; 7: 329-338. http://dx.doi.org/10.1080/13550280152537193 PMid:11517412
11. Berger JR, Houff S. Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab. Neurol. Res 2006; 28: 299-305. http://dx.doi.org/10.1179/016164106X98198 PMid:16687057
12. Khanna N, Wolbers M, Mueller NJ, Garzoni C, Du Pasquier RA, Fux CA et al. JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy. J Virol. 2009; 83: 4404-4411. http://dx.doi.org/10.1128/JVI.02657-08 PMid:19211737 PMCid:2668450
13. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971; 1: 1257-1260. http://dx.doi.org/10.1016/S0140-6736(71)91777-6
14. Koralnik IJ. Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name? Ann Neurol. 2006; 60: 162-173. http://dx.doi.org/10.1002/ana.20933 PMid:16862584
15. D'Souza A, Wilson J, Mukherjee S, Jaiyesimi I. Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia: a report of three cases and review of the literature. Clin Lymphoma Myeloma Leuk 2010; 10: E1-E9. http://dx.doi.org/10.3816/CLML.2010.n.009
16. Rea IM, Alexander HD, Crockard AD, Morris TC. CD4 lymphopenia in very elderly people. Lancet 1996; 347: 328-329. http://dx.doi.org/10.1016/S0140-6736(96)90504-8
17. Zonios DI, Falloon J, Bennett JE, Shaw PA, Chaitt D, Baseler MW et al. Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood 2008; 112: 287-294. http://dx.doi.org/10.1182/blood-2007-12-127878 PMid:18456875 PMCid:2442741
18. Smith DK, Neal JJ, Holmberg SD. Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force. N. Engl. J Med 1993; 328: 373-379. http://dx.doi.org/10.1056/NEJM199302113280601 PMid:8093633
19. Stolt A, Sasnauskas K, Koskela P, Lehtinen M, Dillner J. Seroepidemiology of the human polyomaviruses. J Gen. Virol. 2003; 84: 1499-1504. http://dx.doi.org/10.1099/vir.0.18842-0 PMid:12771419
20. Khorshid O, de ME, Martin T, Jones RB, Shpall EJ, Nieto Y et al. Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplant. Leukemia 2003; 17: 2538-2540. http://dx.doi.org/10.1038/sj.leu.2403163 PMid:14523458
21. Weber T, Trebst C, Frye S, Cinque P, Vago L, Sindic CJ et al. Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infect. Dis. 1997; 176: 250-254. http://dx.doi.org/10.1086/514032 PMid:9207375
22. Manz HJ, Dinsdale HB, Morrin PA. Progressive multifocal leukoencephalopathy after renal transplantation. Demonstration of Papova-like virions. Ann Intern. Med 1971; 75: 77-81. PMid:4933296
23. Van AG, Van RM, Sciot R, Dubois B, Vermeire S, Noman M et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N. Engl. J Med 2005; 353: 362-368. PMid:15947080
24. Kharfan-Dabaja MA, Ayala E, Greene J, Rojiani A, Murtagh FR, Anasetti C. Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature. Bone Marrow Transplant. 2007; 39: 101-107. http://dx.doi.org/10.1038/sj.bmt.1705548 PMid:17143300
25. Yousry TA, Major EO, Ryschkewitsch C, Fahle G, Fischer S, Hou J et al. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N. Engl. J Med 2006; 354: 924-933. http://dx.doi.org/10.1056/NEJMoa054693 PMid:16510746 PMCid:1934511
26. Wenning W, Haghikia A, Laubenberger J, Clifford DB, Behrens PF, Chan A et al. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N. Engl. J Med 2009; 361: 1075-1080. http://dx.doi.org/10.1056/NEJMoa0810257 PMid:19741228
27. Hall CD, Dafni U, Simpson D, Clifford D, Wetherill PE, Cohen B et al. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. N. Engl. J Med 1998; 338: 1345-1351. http://dx.doi.org/10.1056/NEJM199805073381903 PMid:9571254
28. De LA, Giancola ML, Cingolani A, Ammassari A, Gillini L, Murri R et al. Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy. Clin Infect. Dis. 1999; 28: 624-628. http://dx.doi.org/10.1086/515153 PMid:10194089
29. De LA, Giancola ML, Ammassari A, Grisetti S, Cingolani A, Paglia MG et al. Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy. AIDS 2000; 14: F117-F121. http://dx.doi.org/10.1097/00002030-200009290-00001 PMid:11061646
30. De LA, Ammassari A, Pezzotti P, Cinque P, Gasnault J, Berenguer J et al. Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis. AIDS 2008; 22: 1759-1767. http://dx.doi.org/10.1097/QAD.0b013e32830a5043 PMid:18753934
31. Royal W, III, Dupont B, McGuire D, Chang L, Goodkin K, Ernst T et al. Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy. J Neurovirol. 2003; 9: 411-419. http://dx.doi.org/10.1080/713831540 PMid:12775425
32. Cettomai D, McArthur JC. Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy. Arch. Neurol. 2009; 66: 255-258. http://dx.doi.org/10.1001/archneurol.2008.557 PMid:19204164
33. Study to Explore the Effect of Mefloquine in Subjects With Progressive Multifocal Leukoencephalopathy (PML). Pathologe 2011. PMid:12883977
34. Zhang DL, Lapeyraque AL, Popon M, Loirat C, Jacqz-Aigrain E. Pharmacokinetics of ganciclovir in pediatric renal transplant recipients. Pediatric Nephrology 2003; 18: 943-948. http://dx.doi.org/10.1007/s00467-003-1226-x PMid:20190843
35. Fianchi L, Colosimo C, De Luca A, Pompucci A, Cattani P, Voso MT et al. Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto-SCT successfully treated with combination therapy. Bone Marrow Transplant. 2010 Nov;45(11):1668-70. http://dx.doi.org/10.1038/bmt.2010.33 PMid:21225213
36. Silva CA, de Oliveira ACP, Vilas-Boas L, Fink MCDS, Pannuti CS, Vidal JE. Neurologic Cytomegalovirus Complications in Patients with Aids: Retrospective Review of 13 Cases and Review of the Literature. Revista do Instituto de Medicina Tropical de Sao Paulo 2010; 52: 305-310. PMid:21054716
37. da Silva RL, Ferreira I, Teixeira G, Cordeiro D, Mafra M, Costa I et al. BK virus encephalitis with thrombotic microangiopathy in an allogeneic hematopoietic stem cell transplant recipient. Transplant Infectious Disease 2011; 13: 161-167. http://dx.doi.org/10.1111/j.1399-3062.2010.00581.x PMid:18090919
38. Zu-Rhein GM, Lo SC, Hulette CM, Powers JM. A novel cerebral microangiopathy with endothelial cell atypia and multifocal white matter lesions: A direct Mycoplasmal infection? Journal of Neuropathology and Experimental Neurology 2007; 66: 1100-1117. http://dx.doi.org/10.1097/NEN.0b013e31815c1e09 PMid:15804960
39. Eberwein P, Hansen LL, Agostini HT. Genotypes of JC virus, DNAof cytomegalovirus, and proviral DNA of human immunodeficiency virusin eyes of acquired immunodeficiency syndrome patients. Journal of Neurovirology 2005; 11: 58-65. http://dx.doi.org/10.1080/13550280590900391 PMid:12721937
40. Ling PD, Lednicky JA, Keitel WA, Poston DG, White ZS, Peng RS et al. The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: A 14-month longitudinal study. Journal of Infectious Diseases 2003; 187: 1571-1580. http://dx.doi.org/10.1086/374739 PMid:20630132
41. Helantera I, Koskinen P. Association of immune cell function assay with protocol biopsy findings and viral infections in well matched kidney transplant recipients. Clinical Nephrology 2010; 74: 123-131.